In gnathostomes, dorsoventral (D-V) patterning of neural crest cells (NCC) within the pharyngeal arches is crucial for the development of hinged jaws. One of the key signals that mediates this process is Endothelin-1 (EDN1). Loss of EDN1 binding to the Endothelin-A receptor (EDNRA) results in loss of EDNRA signaling and subsequent facial birth defects in humans, mice and zebrafish. A rate-limiting step in this crucial signaling pathway is the conversion of immature EDN1 into a mature active form by Endothelin converting enzyme-1 (ECE1). However, surprisingly little is known about how Ece1 transcription is induced or regulated. We show here that Nkx2.5 is required for proper craniofacial development in zebrafish and acts in part by upregulating ece1 expression. Disruption of nkx2.5 in zebrafish embryos results in defects in both ventral and dorsal pharyngeal arch-derived elements, with changes in ventral arch gene expression consistent with a disruption in Ednra signaling. ece1 mRNA rescues the nkx2.5 morphant phenotype, indicating that Nkx2.5 functions through modulating Ece1 expression or function. These studies illustrate a new function for Nkx2.5 in embryonic development and provide new avenues with which to pursue potential mechanisms underlying human facial disorders.
INTRODUCTION
A diverse set of instructive signals drive dorsoventral patterning of cranial neural crest cells (NCCs) that will eventually form the craniofacial skeleton (Clouthier et al., 2010; Medeiros and Crump, 2012; Trainor and Krumlauf, 2001 ). Many of these signals are highly conserved among gnathostomes, including Endothelin-1 (EDN1) (Clouthier et al., 2013; Medeiros and Crump, 2012) . This peptide is produced in the ectoderm, core mesoderm, and pharyngeal pouch endoderm of the mandibular portion of arch 1 and more caudal arches Kurihara et al., 1994; Maemura et al., 1996; Yanagisawa et al., 1998) while its cognate receptor, the Endothelin-A receptor (EDNRA), is expressed by all cranial NCCs Yanagisawa et al., 1998) .
Endothelin-1 is produced as a pre-pro molecule, and undergoes two processing steps to yield a mature peptide. The first step is cleavage by Furin proteases to yield a 38 amino acid pro (inactive) form of the molecule, referred to as Big Endothelin-1 (Inoue et al., 1989; Yanagisawa, 1994) . While Big Endothelin-1 has some affinity for Endothelin receptors, its activation of receptor signaling is thought to be negligible compared to that of the mature peptide (Inoue et al., 1989; Yanagisawa, 1994; Yanagisawa et al., 1988) . Big Endothelin-1 is subsequently processed into the mature 21 amino acid Endothelin-1 molecule by the membrane-bound neutral metalloprotease Endothelin converting enzyme (ECE) (Xu et al., 1994) . There are two ECE proteins in mouse, humans and zebrafish (ECE1 and ECE2) (Emoto and Yanagisawa, 1995; Krauss et al., 2014; Xu et al., 1994; Yanagisawa et al., 1998) . ECE1 is believed to be the primary converting factor for EDN1 during embryogenesis, as targeted deletion of Ece1, but not of Ece2, leads to facial defects in mouse embryos resembling those observed in Edn1 and Ednra mutant embryos .
Disruption of genes in the EDN1/EDNRA signaling cascade all lead to defects in the ventral craniofacial skeleton (Clouthier et al., 2013) . In mice, loss of Edn1, Ednra or Ece1 leads to the homeotic transformation of mandibular arch-derived structures into more maxillary-like derivatives. A similar homeotic transformation of the lower jaw is observed in individuals with Auriculocondylar Syndrome, in which EDNRA signaling is disrupted Rieder et al., 2012) . Zebrafish possess two ednra genes (ednra1 and ednra2), with knockdown of both leading to jaw defects similar to those observed in mouse Ednra mutants (Nair et al., 2007) . However, a role for ECE1 in craniofacial development is only known in mice, where its loss leads to defects identical to those in Ednra mutants Yanagisawa et al., 1998) . In this study, we have used several approaches to better understand Ece1 function and regulation during zebrafish facial development. Morpholinomediated knockdown of ece1 results in defects similar to those observed in Endothelin pathway mutants, though defects also exist in more dorsal arch derivatives. We also identify Nkx2.5 as a modulator of Ece1 expression, as nkx2.5 morpholino-injected embryos display defects similar to those seen in ece1 morphants. Importantly, ece1 mRNA rescues these defects. Similar changes are observed in a subset of nkx2.5 mutants. These findings reveal that Nkx2.5 is crucial for normal craniofacial development by acting as a novel upstream regulator of Ednra signaling.
RESULTS

Zebrafish ece1 expression in the heart and pharyngeal arches
Examining protein alignments, zebrafish and mouse Ece1 were highly conserved, with 64% identity for the entire protein, and 75% identity when focusing on the C-terminal peptidase domain (Fig. 1A) . In 24 hours post fertilization (hpf) zebrafish embryos, ece1 was ubiquitously expressed at low levels, though higher expression was evident in the pharyngeal arch ectoderm, heart, brain, and intersegmental vessels (Fig. 1B, E) . At 36 hpf, ubiquitous ece1 expression was still present, with higher levels in the heart and intersegmental vessels (Fig. 1C, F) . This pattern was maintained through 48 hpf, with additional ece1 detected in the heart and pectoral fins and in the dorsal aorta (Fig. 1D, G ).
Previous analysis of Ece1 expression in mouse embryos showed weak expression in the arch mesenchyme and surrounding ectoderm between embryonic days (E) 9.5 -E11.5 . However, as EDN1 functions between E8.25 and E9.0 in the mouse (Fukuhara et al., 2004; Ruest and Clouthier, 2009) , we began our analysis at E8.5. At this stage, Ece1 expression was present in the developing heart as well as the mandibular arch ( Fig. 1H and Supplemental Fig. 1 ). At E9.5, Ece1 expression was faintly observed in the first arch and heart (Fig. 1I) . At E10.5, Ece1 was expressed strongly in the heart and otic vesicle, with weak expression present in the maxillary portion of the first arch ( Fig. 1J and Supplemental Fig. 1 ).
Knockdown of ece1 leads to craniofacial defects
Loss of mouse Ece1 disrupts development of mandibular arch-derived structures , though the molecular regulation of Ece1 expression and function during NCC development is unknown. Due to aspects of its early development, the zebrafish model offers an approach to rapidly dissect developmental cues required for NCC patterning, an event that is highly conserved between teleosts and mammals (Clouthier et al., 2010; Schilling and Le Pabic, 2013) . We therefore designed and injected a translation blocking Morpholino (MO) against ece1. Uninjected control (UIC) and ece1 ATG MOembryos were collected at 5 days post fertilization (dpf) and stained with Alcian blue to visualize cartilage. Compared to controls ( Fig. 2A-D) , both ventral and dorsal arch-derived cartilages were hypoplastic and malformed in ece1 morphant embryos ( Fig. 2F-I) ; this included Meckel's cartilage fusing to the palatoquadrate (* in Fig. 2H, I ), thus disrupting the jaw joint that normally forms between the two cartilages )(phenotype observed in 74% of injected embryos; 70/95). Further, the two halves of Meckel's cartilage were fused at the midline and the anterior tip was deflected ventrally. The ceratohyal was also deflected ventrally and fused to the hyosymplectic and only a single set of ceratobranchials were present (Fig. 2H, I ). In addition, the basihyal was extremely hypoplastic (Fig. 2H ). In the dorsal jaw, the palatoquadrate was present, though was hypoplastic and missing the pterygoid process (Fig. 2I) . The hyosymplectic was dysmorphic, with the hyomandibular region hypoplastic and the symplectic region absent (Fig. 2H, I ). Morphants also displayed cardiac edema at 5 dpf, suggestive of a cardiovascular defect (data not shown). These results were confirmed by using a splice blocking MO that blocked splicing of the intron between exons 5 and 6 of the ece1 gene (Supplemental Fig. 2C, D, I ).
While not as efficient, the phenotype in these morphants matched that observed in morphants using the translation blocking (ATG) morpholino (Fig. 2 ) (phenotype observed in 42% of injected embryos; 44/106). Injection of a scrambled ece1 MO affected craniofacial development in only 1.7% (2/117) of morphants (Supplemental Fig. 2E, F) . Importantly, injection of ece1 mRNA with the ece1 splice blocking MO rescued the morphant craniofacial phenotype in 89% (77/87) of embryos at 5 dpf (Supplemental Fig. 2G, H) . These ventral cartilage defects were similar to those observed in edn1 mutant and morphant embryos Miller and Kimmel, 2001; Miller et al., 2000) . As has been previously reported Miller and Kimmel, 2001; Miller et al., 2003) , in edn1 MO-injected embryos, hypoplasia of ventral arch derivatives (Meckel's cartilage and the ceratohyal) was observed ( Fig. 2K-N) (phenotype observed in >50% of injected embryos). In addition, ceratobranchials 1-4 were absent, leaving only the fifth ceratobranchial containing the pharyngeal teeth (Fig. 2M) . Like ece1 MO-injected embryos, Meckel's cartilage was also fused to the palatoquadrate, disrupting the primary jaw joint. However, unlike ece1 morphants, dorsal cartilages were relatively normal (Fig. 2N ).
Due to the similarities in ventral arch structures between edn1 morphants/mutants and ece1 morphants, we examined whether gene expression changes associated with loss of Edn1 function were also observed in ece1 morphants. dlx5a is one the earliest genes induced by Edn1/Ednra signaling (Clouthier and Schilling, 2004; Clouthier et al., 2000) and is expressed throughout the pharyngeal arch mesenchyme early before becoming restricted more dorsally (Fig. 2E and (Clouthier et al., 2000; Talbot et al., 2010) . Loss of EDNRA signaling in mouse embryos leads to loss of almost all pharyngeal arch Dlx5 expression (Ruest et al., 2004) . Similarly, compared to expression of dlx5a in control larvae, dlx5 expression in ece1 morphants was almost completely lost ( Fig. 2J) , similar to the change observed in edn1 morphants (Fig. 2O ) and edn1 mutants (Talbot et al., 2010) . Thus, Ece1 function in zebrafish appears to act in a similar manner during ventral arch patterning as it does in mammals.
Nkx2-5: a potential regulator of ece1 expression
While little is known about the regulation of Ece1 expression in vivo, the human ECE1 promoter can be bound and activated by NKX2-5 in cultured cardiomyoblasts (Funke-Kaiser et al., 2003) . Nkx2-5 is expressed in the core arch mesoderm of the mandibular arch in E8.5 mouse embryos (Kasahara et al., 1998; Komuro and Izumo, 1993) , with NKX2-5 daughter cells present in the overlying arch ectoderm at E10.5 (Moses et al., 2001) . It is therefore possible that NKX2-5 could directly or indirectly regulate Ece1 expression during pharyngeal arch patterning. We first examined the temporal expression pattern of Nkx2-5 in the mouse and found that Nkx2-5 was expressed robustly in the developing heart, pharynx and mandibular arch at E8.5 (Fig. 3A) , similar to previous reports (Kasahara et al., 1998; Komuro and Izumo, 1993; Lyons et al., 1995) . In the arches, Nkx2-5 expression was present in the pharyngeal arch ectoderm and endoderm (Fig. 3B) , with fainter staining present in the mesenchyme. By E9.5, expression was only observed in the heart (Fig. 3C ) and pharynx (Fig. 3D) . By E10.5, Nkx2-5 expression was only present in the heart (Fig. 3E, F) .
To further delineate the tissues derived from Nkx2-5 expressing cells, the fate of Nkx2-5 daughter cells was determined using R26R;Nkx2-5 cre/+ embryos. In E10.5 R26R;Nkx2-5 cre/+ embryos, β-galactosidase (β-gal) staining was detected in all pharyngeal arches (Fig. 3G, H) . Staining was also observed in the caudal region of the maxillary prominences and in scattered cells throughout the head region (Fig. 3G, H) . β-gal activity was confined to the ectoderm, endoderm and mesodermal core (Fig. 3I) , with scattered staining was also apparent lining the capillaries within the arch mesenchyme (Fig. 3J) , likely representing endothelial cells (Paffett-Lugassy et al., 2013) . This correlates with the weak Nkx2-5 expression observed in the mesenchyme of E8.5 embryos (Fig. 3B) . Overall, these findings match well with previous analysis of Nkx2-5 daughter cell fate in the arches (Paffett-Lugassy et al., 2013) .
Zebrafish nkx2.5 is expressed in the pharyngeal mesoderm
To better characterize nkx2.5 expression in the zebrafish pharyngeal arches, we examined embryos beginning at 20 somites and observed nkx2.5 expression in the cardiac precursors condensing at the midline as well as in two lateral domains that correspond to arch mesoderm populations (Fig. 4A, B ). This cardiac expression has been well characterized (Alexander et al., 1998; Goldstein and Fishman, 1998; Reiter et al., 1999; Targoff et al., 2013; Targoff et al., 2008) . By 24 hpf, nkx2.5 expression was observed in the mesoderm of arches 3-6 and more weakly in arch 2, while expression in arch 1 was minimal (Fig. 4C, D) , a pattern matching that observed in nkx2.5:GFP transgenic zebrafish embryos (Choe et al., 2013) . In sectioned embryos, nkx2.5 expression in the arches was primarily observed in the arch mesoderm, surrounded by NCC-derived mesenchyme ( Fig. 4E-G ). nkx2.5 was still expressed robustly in the heart at 30 hpf, though mesodermal expression was more diffuse, encompassing arches 1-4 (Fig. 4H, I ). This temporal pattern resembles that previously observed for nkx2.5+ clusters in developing zebrafish embryos (Paffett-Lugassy et al., 2013) . Expression in the dorsal aorta also became evident at this stage (Fig. 4H, I and Supp. Fig. 3A, B) . By 36 hpf, nkx2.5 expression could be seen in the pectoral fin bud (Supp. Fig.   3C , D). This fin bud expression, as well as heart and dorsal aorta expression, persisted through 48 hpf (Supp. Fig. 3E , F). To confirm that nkx2.5 expression was confined to the arch mesoderm, we performed double fluorescent in situ hybridization (FISH), comparing nkx2.5 expression with the expression of hand2, a ventral mesenchyme marker (Fig. 4J ). In 30 hpf embryos, hand2-positive NCCs could be seen partially surrounding nkx2.5-expressing mesoderm cells in pharyngeal arches 3 and 4, with nkx2.5 expression considerably weaker in arches 1 and 2 (Fig. 4J ).
Loss of zebrafish nkx2.5 leads to defects in pharyngeal arch-derived cartilages
We next examined the function of Nkx2.5 in facial development using MO knockdown. Compared to control embryo skeletons ( Fig. 5A-D) , 63.8% (n=37/58) of 5 dpf nkx2.5 morphants stained with Alcian blue exhibited cartilage malformations, of which we identified three classes. In mild morphants (19% of injected larvae (n=11/58)), ventral deflection of Meckel's and the ceratohyal was observed, though facial cartilages were otherwise normally patterned and joint fusions were not observed (data not shown). In moderate morphants (8.6% of larvae analyzed (n=5/58)), there was a mild ventral deflection of Meckel's cartilage and the ceratohyal, with moderate hypoplasia of the otherwise normally patterned dorsal and ventral arch-derived cartilages and no joint fusions (data not shown). The majority of affected embryos (n=21/58 or 32.6%) fell into the severe class, displaying hypoplasia of all components of the craniofacial skeleton ( Fig. 5E-H ). This also included changes in Meckel's cartilage, which displayed a ventral downturn and inversion towards the midline (Fig. 5E , H). The majority of embryos examined had normal joint formation ( Fig. 5E-H ), though the hyosymplectic was hypoplastic and the ventral region truncated, as were all five sets of ceratobranchials (Fig. 5G, H) . The palatoquadrate was present but malformed, with an absent pterygoid process (Fig. 5H ) and the basihyal was smaller (Fig. 5G ) than observed in control embryos (Fig. 5C ). Morphants also had varying degrees of cardiac edema that did not correlate with the severity of cartilage defects (data not shown). Co-injection with an p53 MO to limit changes due to MO-induced cell death (Robu et al., 2007) did not alter the phenotype (data not shown).
Since MO-mediated gene knockdown can result in variability in the degree of knockdown and produce off-target affects (Kok et al., 2015) , we also assessed craniofacial morphology in a strain carrying a nonsense mutation in the nkx2.5 gene (generated through TILLING: nkx2.5 vu179 ) (Targoff et al., 2013) . Both nkx2.5 mutants and morphants develop ventricular defects, in which ventricular cardiomyocytes transdifferentiate into atrial cardiomyocytes (Targoff et al., 2013; Targoff et al., 2008) . However, while cardiac defects were apparent in all nkx2.5 mutants, the incidence of craniofacial defects in these mutants was 14% (11/77). Most mutants (10/77) displayed a phenotype resembling the mild class of nkx2.5 morphants, in which Meckel's cartilage was slightly downturned and other viscerocranial elements were slightly hypoplastic (data not shown). However, one mutant displayed a phenotype similar to the severe class of nkx2.5 morphants, including a downturned Meckel's cartilage containing a slight inversion of the anterior tip and overall hypoplasia of other viscerocranial elements , including the basihyal (Fig. 5K) . One difference between mutants and morphants was that the pterygoid process of the palatoquadrate was present in nkx2.5 mutants compared to its absence in nkx2.5 MO-injected embryos. While there are several reasons that could account for the low penetrance of facial defects in nkx2.5 mutants (discussed below), the overall phenotypic similarity between the MO and mutant phenotypes suggests that the use of our nkx2.5 MO is a valid approach. To further study Nkx2.5 function during facial development in an efficient manner, we focused the remainder of our analysis on Nkx-deficient (MO-injected) embryos, as we could generate large numbers of these embryos more easily than would be feasible using nkx2.5 mutants, considering the low frequency with which facial defects occurred in mutants.
The ventral defects observed in nkx2.5 MO-injected embryos are similar to those seen in Endothelin signaling pathway mutants, including furinA, plcβ3, mef2c, edn1 and ednra1/2 morphants/mutants (Miller et al., 2000; Nair et al., 2007; Talbot et al., 2010; Walker et al., 2006) . Since ventrally-restricted hand2 expression is disrupted in Endothelin pathway mutants and is suggestive of defects in D-V patterning (Clouthier et al., 2010) , we examined a hand2 reporter transgenic line in which the zebrafish pharyngeal archspecific enhancer for hand2 drives expression of mCherry (Ikle et al., 2012) . In control embryos at 28 hpf, mCherry fluorescence was present in the ventral domain of the pharyngeal arches in a pattern similar to endogenous hand2 expression ( Fig. 5M and data not shown). Following nkx2.5 knockdown, mCherry fluorescence was dramatically reduced (Fig. 5N ).
Nkx2-5 −/− mouse embryos die by E10.0 due to vascular defects (Lyons et al., 1995; Tanaka et al., 1999) . However, if the function of NKX2-5 is conserved between mouse and zebrafish, changes in early gene expression should also be conserved. We therefore examined expression of Hand2 in E9.25 Nkx2-5 cre/cre embryos, in which the Nkx2-5 gene is disrupted due to the presence of a Cre expression cassette within the Nkx2-5 locus (Moses et al., 2001) . Though Hand2 expression comes on shortly before E9.25, weak Hand2 expression was already observed in the ventral half of the mandibular arch of control embryos (Fig. 5O) . In contrast, Hand2 expression was absent from the pharyngeal arches of Nkx2-5 cre/cre embryos (Fig. 5P) , mirroring the loss we observed in nkx2.5 morphant zebrafish.
Early pharyngeal arch patterning is disrupted in nkx2.5 morphants
To better understand the changes in the ventral, intermediate and dorsal pharyngeal arch domains, we examined expression of markers for each of these domains in wild type and nkx2.5 MO-injected embryos. dlx5a and dlx6a are key mediators of Ednra signaling (Clouthier et al., 2013) . Expression of dlx5a in control embryos was observed in arches one and two (Fig. 6A) , with expression appearing unchanged in nkx2.5 morphants (Fig. 6B) , in contrast to findings in both mouse and zebrafish Endothelin pathway mutants (Charité et al., 2001; Ruest et al., 2004) Walker et al., 2006) . In contrast, arch expression of dlx6a, also regulated by Ednra signaling (Charité et al., 2001; Ruest et al., 2004; Walker et al., 2006) , was decreased in nkx2.5 morphants compared to control embryos (Fig. 6C, D) . Similar to our findings with mCherry fluorescence (Fig. 5N ), hand2 expression in the pharyngeal arches was almost completely lost in nkx2.5 morphants (Fig. 6F, H ) compared to control embryos (Fig. 6E, G) . In contrast, expression of dlx2a, which exhibits normal ventral arch expression in zebrafish edn1 mutants (Miller et al., 2000) but is downregulated in ednrA1/ednrA2 morphants (Nair et al., 2007) , appeared slightly upregulated in nkx2.5 morphants (Fig. 6J ) compared to control embryos (Fig. 6I ). In addition, expression of dlx3b, an intermediate arch domain marker (Fig. 6K ) whose expression is downregulated in Endothelin mutants (Clouthier et al., 2010; Talbot et al., 2010) , was also absent in nkx2.5 morphants (Fig. 6L ).
The discordance in dlx5a gene expression compared to the other observed changes was surprising, though this could reflect the level of gene expression change, as small changes in gene expression can be difficult to detect by ISH (Vieux-Rochas et al., 2010) . We therefore performed quantitative RT-PCR using total RNA from 24 hpf control and nkx2.5 morphant embryos. This analysis revealed that expression of both dlx5a and dlx6a were significantly downregulated, with dlx6a expression (0.51) lower than that of dlx5a (0.76), matching the ISH results (Fig. 6Q) . Expression of hand2 (0.72) and dlx3b (0.54) were also downregulated, with remaining expression likely due to gene expression at other sites in the embryo (Fig.  6Q ). While expression of dlx2a appeared increased by ISH, the increase was not statistically significant as determined by qRT-PCR. Thus, knockdown of nkx2.5 expression leads to gene expression changes that resemble those of other Endothelin pathway mutant/morphants.
Loss of Nkx2.5 impacts expression of Endothelin pathway family members
The ventral defects and early gene expression changes observed in nkx2.5 morphants are similar to those seen in ece1 morphants, suggesting a potential relationship between Nkx2.5 and Ece1. Because the human ECE1 promoter can be bound and activated by NKX2-5 in cardiomyoblasts (Funke-Kaiser et al., 2003) , we examined whether Ece1 was a potential Nkx2.5 target within the Ednra signaling pathway. By ISH, ece1 expression was decreased in the pharyngeal arches of nkx2.5 morphants at 24 hpf (Fig. 6N ) compared to the expression of ece1 expression in control embryos (Fig. 6M) . By qRT-PCR, expression was unchanged in nkx2.5 morphant embryos (Fig. 6Q) , potentially indicating that expression was unaffected in other areas of the embryo in which ece1 is expressed Yanagisawa et al., 1998) . To determine if loss of Nkx2.5 also affected edn1 transcription, we examined edn1 expression in control and nkx2.5 morphant larvae at 24 hpf ( Fig. 6O, P) . edn1 expression was detected in the pharyngeal arch ectoderm in both wild type (Fig. 6O ) and nkx2.5 MO-injected (Fig. 6P ) larvae, though expression in nkx2.5 morphants appeared slightly lower. By qRT-PCR, expression was downregulated ~50% in nkx2.5 morphants (Fig. 6Q ). While these experiments cannot determine whether the function of Nkx2.5 on ece1 is direct or indirect, it does appear that loss of Nkx2.5 disrupts the Endothelin signaling network at several points.
During ventricular development, Nkx2.5 and Nkx2.7 function together to maintain ventricular identity (Targoff et al., 2013; Targoff et al., 2008) . We thus examined whether downregulation of Nkx2.5 in nkx2.5 morphants affected nkx2.7 expression. By qRT-PCR, the expression of nkx2.7 was downregulated ~25% (Fig 6Q) . While it is unknown whether Nkx2.5 can induce nkx2.7 expression in vivo, our results suggest that the Nkx2.5 phenotype may represent a broader change in Nkx gene expression.
Craniofacial defects in nkx2.5 MO-injected embryos are rescued with ece1 mRNA To determine whether Nkx2.5 was required for ece1 expression, we attempted to rescue the nkx2.5 morphant phenotype by over-expressing ece1. Capped ece1 mRNA was injected at the one-cell stage, followed by injection of the nkx2.5 MO, with larvae analyzed at 5 dpf for cartilage development. nkx2.5 morphants had defects in viscerocranial and neurocranial elements and occasional joint fusions ( Fig. 5E-H; Fig. 7E-G) , while overexpression of ece1 mRNA alone did not result in obvious changes in arch-derived elements (Fig. 7I-K) . However, co-injection of ece1 mRNA led to a dramatic rescue in development of archderived elements in nkx2.5 morphants (Fig. 7M-O) . As described above, quantification of nkx2.5 morphants showed that 63.8% (n=37/58) exhibited cartilage malformations with the nkx2.5 MO alone (Fig. 7Q ). When coinjected with ece1 mRNA, the number of malformed embryos dropped to 31.1% (n=23/74), representing a 51% rescue over MO injection alone. Further, embryos exhibiting severe defects showed the highest degree of rescue, with the incidence of defects going from 36.2% (n=21/58) when embryos were injected with MO alone to 12.2% (n=9/74) when co-injected with MO and ece1 mRNA (Fig. 7Q ). This represents a 66.3% rescue of severe defects. The incidence of moderate and mild defects also decreased in nkx2.5 morphants receiving ece1 mRNA, though it was not possible to determine whether embryos that still had moderate or mild defects actually represented formally severe mutants with improved cartilage development.
One explanation of improved ventral cartilage development in nkx2.5 morphants also receiving ece1 mRNA is that early gene expression associated with pharyngeal arch patterning was rescued. We thus examined the change in hand2 expression within the ventral arch of MO and MO/mRNA embryos. Injection of the nkx2.5 MO led to a significant downregulation of hand2 expression in the pharyngeal arches (Fig. 7H) . hand2 expression following injection of ece1 mRNA appeared similar to that observed in control embryos (Fig. 7L) . In contrast, nkx2.5 morphants also receiving ece1 mRNA displayed increased hand2 expression (Fig. 7P ) compared to MO injection alone (Fig. 7H) , although it did not appear to reach the level observed in control embryos (Fig. 7D) . Thus, the observed rescue of ventral arch defects in nkx2.5 MO-injected embryos by ece1 mRNA does involve partial restoration of the Endothelin signaling network.
DISCUSSION
Edn1/Ednra signaling is one of the key events during D-V patterning of NCCs in the pharyngeal arches in gnathostomes (jawed vertebrates) (Clouthier et al., 2013) . Loss of this signaling leads to defects in ventral and intermediate arch derivatives. The key regulatory step is the processing of big EDN1 into mature EDN1 by ECE1 (Xu et al., 1994) . We have shown here that Nkx2.5 is a key regulator of ece1 expression in both mouse and zebrafish and thus has a critical role in facial morphogenesis not previously recognized.
Penetrance of the craniofacial defects in nkx2.5 mutants While nkx2.5 morphant and mutant embryos have similar craniofacial defects, the penetrance of such defects in nkx2.5 mutants is low. This may relate to the sensitivity of Ednra signaling to modifier effects. Mutations in the gene encoding PLCB4, part of the intracellular signaling pathway induced by EDNRA signaling, result in Auriculocondylar Syndrome (ACS) in humans, though the severity of the phenotype can vary among family members carrying the same mutation (Rieder et al., 2012) . Likewise, mutations in NKX2-5 are associated with congenital heart disease (CHD) (Reamon-Buettner and Borlak, 2010), though identical mutations within NKX2-5 can result in different CHDs in different individuals (Abou Hassan et al., 2015; Reamon-Buettner and Borlak, 2010) . These findings illustrate that EDNRA signaling may be particularly sensitive to the action of genetic modifiers.
Another possibility is that the morphant phenotype reflects off-target effects of the morpholino. Recently, Kok et al. showed that morphant phenotypes in 80 different genes were not recapitulated in 80% of corresponding mutant fish (Kok et al., 2015) . However, there are several plausible explanations that could explain this discordance besides off-target effects (Blum et al., 2015) . Mutations generated by TILLING or genome editing may represent hypomorphic alleles due to incomplete loss of function or continued expression of a portion of the mutant gene due to cryptic start sites or altered splicing . In these instances, a morpholino knockdown of the same gene could result in a more complete loss of gene function. In addition, at least some genetic pathways can compensate for complete gene loss, but not for gene knockdown, by upregulating other genes . Such compensation during facial development is observed between Msx1 and Msx2 (Han et al., 2007) . In this case, a strong loss of function allele would result in the activation of a compensatory mechanism whereas low level gene expression in morphants would be above the threshold for induction of compensation. More detailed interrogation of potential compensation for loss of Nkx2.5 function is required to address these questions.
ECE1/NKX2-5 functions in mouse and zebrafish facial morphogenesis
In Nkx2-5 cre/+ embryos, Nkx2-5 daughter cells were present in the pharyngeal arch ectoderm (Moses et al., 2001 ) and core mesoderm and vasculature (Paffett-Lugassy et al., 2013) at E10.5. We have shown here that these Nkx2-5 lineage cells first express Nkx2-5 around E8.5 for less than 24 hours, corresponding to the time during which EDNRA signaling establishes D-V polarity within the pharyngeal arches (Fukuhara et al., 2004; Ruest and Clouthier, 2009 ). After E9.5, EDNRA signaling is no longer required (Ruest et al., 2005) , likely due in part to the function of BMPs (Alexander et al., 2011) . This matches well with our expression data showing that mouse Nkx2-5 expression is normally downregulated after E9.5. However, while ventral arch defects are similar to those observed in other Endothelin-pathway mutants, ece1 morphants and nkx2.5 morphants and mutants also had defects in dorsal arch cartilages. Interestingly, in Ednra −/− mouse embryos, bones that compose the zygomatic arch (including the jugal) are hypoplastic (Ruest et al., 2004) , suggesting that EDNRA signaling also contributes to the development of more posterior maxillary derivatives that derive from the dorsal mandibular arch. It is worth noting that the zebrafish edn1 mutation (Miller et al., 2000) is likely not a complete loss-of-function allele (Jamie Nichols, personal communication), meaning that the edn1 mutant phenotype may actually only produce a hypomorphic craniofacial phenotype. Answering these questions will require in depth structural analysis and earlier gene expression profiling.
Another explanation for the defects in dorsal derivatives is that Nkx2.5-induced Ece1 activity (either direct or indirect) is required for the processing of other proteins beside Edn1. While one candidate is Edn3, a molecule required for iridophore development in zebrafish larva (Krauss et al., 2014) , EDN3 does not play a role in murine facial development (Baynash et al., 1994) and has a weak binding affinity for Ednra (Breu et al., 1995; Lee et al., 1994) . Besides EDNs, metalloproteases like ECE1 (including neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE)) often have broad specificity; indeed, ECE1 can hydrolyze a number of peptides, including bradykinin, neurotensin, substance P and atrial natriuretic peptide (ANP) (Johnson et al., 1999; Nakayama et al., 2012) . Based on phylogeny, Ece1 has a more ancient origin than does Edn1, further suggesting functional roles outside of big Edn1 cleavage (Hyndman and Evans, 2007) . While these findings suggest that ECE proteins can act on other proteins, further experiments are required to determine whether the function of such proteins can explain the dorsal defects observed in nkx2.5 morphants and mutants.
Like our results shown here, knockdown of grainyhead-like 3 (grhl3) in zebrafish embryos also results in defects in both dorsal and ventral cartilage derivatives of the first arch (Dworkin et al., 2014) . grhl3 morphants have elevated cell death and decreased proliferation within the arches, accounting for the hypoplasia. Grhl3 appears to induce edn1 expression, leading to the hypothesis that loss of Endothelin signaling is the underlying cause of the Iklé et al. Page 10 Genesis. Author manuscript; available in PMC 2018 March 01.
grhl3 morphant phenotype. This is supported by the finding in zebrafish that Edn1 promotes both early patterning and proliferation of the NCC-derived mesenchyme in the mandibular arch (Sasaki et al., 2013) and raise the possibility that Endothelin signaling is involved in the development of a greater array of facial elements than previously thought. In addition, this may strengthen the idea that Nkx2.5 regulates both ece1 and edn1 expression. We showed that ece1 levels changed by ISH but not by qRT-PCR, while edn1 levels changed in both assays. As previously mentioned, Ece1 expression in mice is quite broad, so a failure to see downregulation by qRT-PCR may be due to continued expression elsewhere in the larvae. In addition, it is unclear how absence of Edn1 alone could be rescued by additional Ece1, considering that the level of Ece1 is normally sufficient for craniofacial development. While NKX2-5 can regulate rat Ece1 expression (Funke-Kaiser et al., 2003) , human EDN1 expression appears to be negatively regulated by NKX2-3 (Yu et al., 2011) . As our qRT-PCR for edn1 and ece1 in nkx2.5 morphants illustrate, understanding Nkx2.5 function during facial morphogenesis will require dissecting its individual roles in regulating the expression of Endothelin pathway members.
Gene expression changes in nkx2.5 morphants
Members of the Dlx family of transcription factors are also crucial mediators of Ednra signaling. The loss of dlx3b but not dlx2a in nkx2.5 morphants is similar to what has been observed in edn1 mutants (Walker et al., 2006) , though the reduction in dlx5a and dlx6a expression, while present, was more modest compared to edn1 mutants. However, DLX5/ DLX6 directly activates Hand2 expression (Charité et al., 2001) . As hand2 expression decreased in both nkx2.5 MO-injected embryos and Nkx2-5 mutant mouse embryos, this modest reduction in dlx5a/6a expression in the morphants is functionally sufficient to impact downstream effectors. While it is possible that Nkx2.5 directly activates the hand2 arch enhancer (through putative Nkx2.5 binding sites in the enhancer (Ikle et al., 2012) ), hand2 expression in the lateral plate mesoderm is unaffected in nxk2.5 mutants (Targoff et al., 2013) , arguing against this possibility. Further, both Hand2 and Dlx3 are transcriptionally downstream of DLX5/DLX6 (Barron et al., 2011; Depew et al., 2002) . As dlx3b expression is lost in nkx2.5 MO-injected embryos, Nkx2.5 must be acting in part upstream of Hand2.
That Dlx gene expression is not lower could suggest that other signaling pathways can partially compensate for loss of Edn1 activity following knockdown of nkx2.5, one candidate being Bmp signaling (Alexander et al., 2011) . In addition, we cannot rule out that Ece2a/b can compensate for loss of Ece1, though such compensation in mice is not observed . Thus, decreased Nkx2.5 levels are sufficient to disrupt the Endothelin signaling pathway.
Coordination of Nkx family members in transcriptional regulation
The zebrafish genome contains two additional NKX2-5 paralogs: Nkx2.3 and Nkx2.7. In vertebrates, NKX molecules often act cooperatively or redundantly to regulate developmental processes. Pharynx development is disrupted in mice lacking both Nkx2-5 and Nkx2-6 (Tanaka et al., 2001) , though loss of either individually has no effect on the pharynx (Tanaka et al., 1999; Tanaka et al., 2000) . Similar relationships are also seen in Nkx function during zebrafish cardiac development. As previously mentioned, loss of nkx2.5 results in loss of ventricular cardiomyocytes and concomitant increase in atrial Iklé et al. Page 11 Genesis. Author manuscript; available in PMC 2018 March 01.
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Author Manuscript Author Manuscript cardiomyocytes (Targoff et al., 2008) . While loss of nkx2.7 results in very mild ventricular defects, loss of nkx2.7 in a nkx2.5 mutant background greatly exacerbates the ventricular phenotype, illustrating that Nkx proteins function cooperatively to maintain ventricular identity of cardiomyocytes (Targoff et al., 2013) . Though relationship of Nkx2.5 and Nkx2.7 to each other's expression profiles is not known for ventricular development, we showed that global nkx2.7 expression is downregulated in nkx2.5 morphants, indicating that the relationship of these two Nkx genes may be complex and involve transcription and posttranscriptional components. It will therefore be important to determine whether facial morphogenesis is disrupted in nkx2.5/nkx2.7 double mutants, whether this is reflected in more severe changes in early arch gene expression and whether this accounts for the low penetrance of facial defects in nkx2.5 mutants alone. It is worth noting that jaw abnormalities have been reported in nkx2.5/2.7 double morphants (Targoff et al., 2008) . It is also possible that Nkx2.3 can function cooperatively or redundantly with Nkx2.5 during cranial NCC patterning, though nkx2.3 expression occurs in the pharyngeal endoderm and ectoderm (Biben et al., 2002; Pabst et al., 1997) . Since nkx2.5 expression occurs in the mesoderm (this study and (Choe et al., 2013) ), a redundant or shared contribution towards NCC development is harder to envision. Analysis of facial development in nkx2.3 mutants will be required to better understand this possibility.
Recent discoveries have linked changes in EDNRA signaling to human birth defect syndromes, including Auriculocondylar Syndrome (ACS) (Gordon et al., 2015) and Mandibulofacial Dysostosis with Alopecia (Gordon et al., 2015) . However, many other human birth defect syndromes exist with similar craniofacial phenotypes but without defined genetic changes. Our study provides novel evidence that NKX2-5 should be considered a new EDNRA pathway component and potential target in gene-phenotype investigations when investigating craniofacial dysmorphologies.
MATERIALS AND METHODS
Animal Use
All animal use was approved by Institutional Animal Care and Use Committees at the University of Indiana, University of California, San Diego, Columbia University and the University of Colorado Anschutz Medical Campus and in accordance with "Guide for Care and Use of Laboratory Animals", as defined by NIH.
Fish strains and genotyping-Fish were raised and maintained under standard conditions (Westerfield, 1993) . Zebrafish embryos for morpholino injection were collected from natural matings of TAB wild type fish; embryos were cultured and staged as described (Kimmel et al., 1995) . Generation and genotyping of the nkx2.5 vu179 allele has been previously described (Targoff et al., 2013) . The mutation is recessive lethal and acts as a loss-of-function allele. The strain is available upon request.
Mouse strains and genotyping-Creation and genotyping of the B6.129S4-Gt(ROSA)26Sor tm1Sor /J (R26R) strain (Jackson Laboratories Stock #003474) has been previously described (Soriano, 1999) , as has the creation of B6129S1-Nkx2-5 tm1(cre)Rjs /J (Nkx2-5 cre ) mutant mice (Moses et al., 2001 )(Jackson Laboratories Stock #030047). For the latter, a Cre expression cassette was inserted in frame in place of exon 2 of Nkx2-5, in essence creating a null allele of Nkx2-5 (Moses et al., 2001 ). Nkx2-5 cre/cre embryos die around E10.0 from cardiovascular defects similar to those observed in Nkx2-5 −/− embryos (Lyons et al., 1995) . Genotyping was performed using a general Cre identification protocol (Tavares et al., 2012) . For embryonic staging, E0.5 was defined as the morning that the vaginal plug was observed.
Morpholino oligonucleotide injection
Morpholinos were diluted to 2.5 ng/nl and injected into embryos at the 1-4 cell stage using an Olympus SZX16 stereomicroscope and a Harvard Apparatus Pico Injector PLI-100. Either 2.5% fluorescein dextran (10,000 MW, lysine fixable, Invitrogen) or 0.1% phenol red was used to track injections. An edn1 translation blocking morpholino was synthesized by
Gene Tools (Eugene, OR) using a previously published sequence ). This morpholino elicits joint fusions and loss of cartilage consistent with loss of Endothelin-1. A nkx2.5 translation blocking morpholino was synthesized by Gene Tools using a previously published sequence (Targoff et al., 2008; Tu et al., 2009) . To knockdown Ece1 function, a translation blocking morpholino was designed to the translation start sequence of ece1 (5'-AAGTAGACATCTGAGGGAAATGTAC-3'). An ece1 splice blocking morpholino was designed to inhibit splicing of exon 5 and exon 6 (5'-TGTGTGTATCTGAGGTCACCTGATT-3'). A dose-response curve identified 5 ng of morpholino as a moderate dose that routinely resulted in craniofacial phenotypes with only minimal lethality. To control for specificity of the ece1 morpholinos, we also designed and injected an ece1 scrambled morpholino (5'-AACTACACATCTCAGGCAAATCTAC-3'). All morpholinos were synthesized by Gene Tools. To suppress potential morpholino-induced cell death, morpholino injections also included 2 ng of a p53 morpholino (Robu et al., 2007) .
Efficacy of the ece1 splice blocking morpholino was confirmed by reverse transcription (RT)-PCR using the following primers: 5'-TCAGCAACCTGTGGGAACAT-3' (in exon 4) and 5'-CTCCTGGAAGTTATCCTTCTC-3' (in exon 6). As the design of the ece1 morpholino should result in exon skipping (Draper et al., 2001) , RT-PCR using these primers should result in a 224 bp band when splicing occurs properly and a 99 bp band when splicing is disrupted (thus excluding exon 5).
mRNA synthesis and injection ece1 mRNA was synthesized from the pExpress-ece1 plasmid (Open Biosystems) using the SP6 mMESSAGE mMACHINE In Vitro Transcription Kit (Ambion). ece1 mRNA was diluted in nuclease-free water and mixed with 2.5% fluorescein dextran for a final concentration of 200 ng/ul. 1 nl of solution was injected into zebrafish embryos at the single cell stage as described above.
Bone and cartilage staining
Zebrafish larvae were anesthetized in Tricaine, then fixed for 1 hour in 4% paraformaldehyde (PFA). Alcian blue and alizarin red staining was performed as previously described .
Whole mount in situ hybridization (ISH)
For ISH analysis in zebrafish, at least 20 embryos were examined per probe. Embryos were collected from wild-type matings and fixed in 4% paraformaldehyde. Embryos to be used for later stages were placed in phenylthiourea (PTU) at 24 hpf to prevent pigment formation. Antisense RNA probes were synthesized from cDNAs and labeled with digoxigenin using the DIG RNA Labeling kit (Roche). The nkx2.5 ISH probe was created by cutting a nkx2.5 cDNA (cloned into pME18S-FL3; Open Biosystems) with EcoRI and NotI and then subcloning into pBluescriptSK+ cut with EcoRI and NotI. The resulting plasmid was linearized with EcoRI and labeled antisense RNA probe synthesized using T3 RNA polymerase and the DIG RNA Labeling kit (Roche). ece1 probe was created from an ece1 cDNA (in pExpress-1; Open Biosystems) linearized with BamHI and labeled using T7 RNA polymerase. Published probes included dlx2a, dlx3b, dlx5a and dlx6a (Talbot et al., 2010) (gifts from C. Kimmel), hand2 and edn1 (Alexander et al., 2011) (gifts from T. Schilling).
Whole mount ISH was adapted from previously described protocols (Ikle et al., 2012) . Embryos were mounted in 100% glycerol, coverslipped, and photographed under brightfield using an Olympus BX51 compound microscope fitted with a DP71 digital camera. For sectional analysis, stained zebrafish embryos were embedded in agar as described (Westerfield, 1993) . 30 micron sections were cut and photographed under Nomarski optics on an Olympus BX51 microscope.
For fluorescent ISH, probes were labeled and developed as described (Talbot et al., 2010) . Embryos were mounted in 100% glycerol and imaged using an Olympus BX51 compound microscope and a DP-71 digital camera.
Whole mount ISH analysis in mouse embryos (n=3) was performed as previously described .
Sectional in situ hybridization
Embryos were fixed overnight in 4% PFA at 4°C, then transferred to a 30% sucrose solution until the embryo sank. Following a 1:1 Sucrose:OCT wash for 1 hour, embryos were embedded in OCT, with 12 micron sections cut using a Leica 3700 cryostat. ISH was then performed as previously described (Hendershot et al., 2007) . Analysis and photography of stained sections was performed as described above.
Real time PCR
Control and nkx2.5 morphant embryos were collected at 24 hpf into TRI reagent (Zymo Research), homogenized and stored at −80°C. For RNA collection, 40-50 larvae were pooled; this was performed for three separate morpholino injections. RNA was collected using the Direct-zol RNA MiniPrep kit (Zymo Research). Samples were DNase I-treated to eliminate gDNA contamination. cDNA was prepared from total RNA using the Quantitect cDNA Synthesis Kit (Qiagen). Real Time quantitative PCR was performed using the reagents and protocols from the Quantitect SYBR Green PCR Kit (Qiagen). Quantitect Assay primers (predesigned primers from Qiagen against hand2, dlx2a, dlx3b, dlx5a, dlx6a, edn1, nkx2.5 and nkx2.7) were resuspended to a 10× stock as recommended by the manufacturer; primers were used at a 1× concentration. To amplify ece1, the following expression is more concentrated in the anterior arches, with expression also in somites and intersegmental vessel (C, F). At 48 hpf, ece1 is detectable in the heart and fin bud (fb) in The ceratohyal (ch) is also defected downward and smaller, as is the basihyal (bh). J. dlx5a expression is downregulated in arches one and two in ece1 morphants. K-N. In edn1 morphants, there is a reduction in ventral cartilages and loss of joints. This includes a severely downturned Meckel's cartilage (mc) that is fused with the palatoquadrate (asterisk in N). The ceratohyal is also pulled ventrally and fused with hyomandibular region, with the symplectic region of the hyosymplectic absent (*)(N). Only the fifth ceratobranchial containing the pharyngeal teeth (t) are present (N). O. dlx5a expression is completely downregulated in arches one and two in edn1 morphants. cb 1-5, ceratobranchials 1-5; bsr, branchiostegal rays; op, opercle. expression in observed in the heart (h) and ectoderm of the first pharyngeal arch (1) and pharynx (ph), with scattered staining present in the first arch mesenchyme. C, D. In E9.5 embryos, Nkx2-5 is strongly expressed in the heart and pharynx, but arch expression is lost. E, F. By E10.5, Nkx2-5 expression is only observed in the heart. G-J. β-galactosidase (β-gal) staining in E10.5 R26R;Nkx2-5-Cre embryos. Strong staining (representing Nkx2-5 daughter cells) is observed throughout the ectoderm of the pharyngeal arches and in the heart. Sections through the mandibular arch (1) show β-gal staining in the pharyngeal arch ectoderm, endoderm and mesodermal core (m) (I, J). Higher magnification shows that the β-gal staining is present in the developing vasculature (arrows in J), while the NCC-derived mesenchyme is unstained. 1-4, pharyngeal arches 1-4; ov, otic vesicle.
expression in the arch mesoderm is decreased. J. Lateral view following double fluorescent ISH for nkx2.5 (red) and hand2 (green) in 30 hpf zebrafish embryo. nkx2.5 is localized in the arch mesoderm medial to NCCs, labeled by hand2. Both nkx2.5 and hand2 are expressed in the heart at this stage. Iklé et al. Page 26 Genesis. Author manuscript; available in PMC 2018 March 01.
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Author Manuscript transgenic zebrafish, mCherry fluorescence is driven in the pharyngeal arches by the zebrafish hand2 pharyngeal arch enhancer (M). In nkx2.5 morphants, fluorescence is reduced (N). O, P. Expression of Hand2 in the mandibular arch of E9.5 control embryos (O) is absent the mandibular arch of E9.5 Nkx2-5 cre/cre embryos (P). Genesis. Author manuscript; available in PMC 2018 March 01.
